Bilateral Vocal Cord Carcinoma in a Sarcoidosis Patient during Infliximab Therapy
Introduction. Although the role of TNF-α in tumor development is not fully understood, an increased risk of malignancy with TNF-α-inhibitors, such as infliximab, has been suggested. Case Presentation. We present a 54-year-old nonsmoking female sarcoidosis patient. After seven months of infliximab th...
Main Authors: | Adriane D. M. Vorselaars, Elisabeth V. Sjögren, Coline H. M. van Moorsel, Jan C. Grutters |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Case Reports in Pulmonology |
Online Access: | http://dx.doi.org/10.1155/2013/308092 |
Similar Items
-
Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients
by: Bas JM Peters, et al.
Published: (2021-02-01) -
Infliximab Treatment of Refractory Cardiac Sarcoidosis
by: Majid Asawaeer, MD, et al.
Published: (2020-08-01) -
Unusual cause of bilateral vocal cord paralysis
by: W M Hajjar, et al.
Published: (2016-01-01) -
Pediatric gastrointestinal sarcoidosis: Successful treatment with infliximab
by: Laila Alawdah, et al.
Published: (2016-01-01) -
Medical image of the week: bilateral vocal cord paralysis
by: Van Hook CJ, et al.
Published: (2017-08-01)